"Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
27072821
DOI
10.1007/s00428-016-1936-7
PII: 10.1007/s00428-016-1936-7
Knihovny.cz E-zdroje
- Klíčová slova
- Array CGH, FISH, Immunohistochemistry, Kidney, Mucin, Mucin-like secretion, Papillary renal cell carcinoma,
- MeSH
- antigeny nádorové metabolismus MeSH
- hybridizace in situ fluorescenční metody MeSH
- imunohistochemie metody MeSH
- karcinom z renálních buněk genetika metabolismus patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- muciny analýza MeSH
- nádorové biomarkery analýza MeSH
- nádory ledvin genetika metabolismus patologie MeSH
- papilární karcinom patologie MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antigeny nádorové MeSH
- muciny MeSH
- nádorové biomarkery MeSH
Mucin and mucin-like material are features of mucinous tubular and spindle renal cell carcinoma (MTS RCC) but are rarely seen in papillary renal cell carcinoma (PRCC). We reviewed 1311 PRCC and identified 7 tumors containing extracellular and/or intracellular mucinous/mucin-like material (labeled as PRCCM). We analyzed these using morphological, histochemical, immunohistochemical, and molecular genetic methods (arrayCGH, FISH). Clinical data were available for six of the seven patients (five males and one female, age range 61-78 years). Follow-up was available for four patients (2-4 years); one patient died of widespread metastases. Tumor size ranged from 3 to 5 cm (mean 3.8). Of all cases, histological architecture showed a predominantly papillary pattern. Mucin or mucin-like was extracellular in one, intracellular in three, and both intra/extracellular in three cases. All tumors were positive for AMACR, vimentin, and OSCAR, while CK7 was positive in four. Mucicarmine stain was positive in all cases, PAS in six and Alcian blue in three cases. Five tumors were positive for MUC 1, but none were positive for MUC 2, MUC 4, or MUC 6. In only four cases, genetic analysis could be performed. Gain of chromosomes 7 and 17 was found in two cases; gain of 17 only was found in one case. Loss of heterozygosity of 3p was found in one case together with polysomy of chromosomes 7 and 17. No abnormalities of VHL, fumarate dehydrogenase, and TFE3 genes were detected. We conclude that PRCCM is a rare but challenging subtype of RCC that deserves to be further studied. In all the tumors, the mucin-like material was found in those stained with mucicarmin, but other conventional and immunohistochemical stains did not reveal consistent features of a single mucin. The molecular-genetic profile of these tumors was most consistent with that of typical papillary RCC, although one case had mixed genetic features of papillary and clear RCC. PRCCM has metastatic potential, as evidenced by one case with widespread metastases. It remains to be determined whether PRCCM represents a unique tumor subtype, deserving to be distinguished from other subtypes of PRCC.
Biomedical Centre Faculty of Medicine in Plzen Charles University Prague Plzen Czech Republic
Department of Pathology Instituto Nacional de Cancerologia Mexico City Mexico
Department of Pathology University Hospital Sarajevo Sarajevo Bosna and Hercegovina
Department of Pathology University Hospital Split Split Croatia
Pathology Department Clinical Hospital Center Sestre milosrdnice Zagreb Croatia
Zobrazit více v PubMed
Am J Surg Pathol. 2012 Mar;36(3):432-42 PubMed
Am J Surg Pathol. 1998 Aug;22(8):1037-40 PubMed
Hum Pathol. 2002 Jan;33(1):60-7 PubMed
Histol Histopathol. 2001 Apr;16(2):387-92 PubMed
Virchows Arch. 2013 Oct;463(4):563-73 PubMed
Br J Urol. 1971 Feb;43(1):4-15 PubMed
Am J Surg Pathol. 2013 Oct;37(10):1469-89 PubMed
Virchows Arch. 2000 Feb;436(2):119-26 PubMed
Front Biosci. 2001 Oct 01;6:D1207-15 PubMed
Pathol Res Pract. 1999;195(1):11-7 PubMed
Urol Oncol. 2009 Jan-Feb;27(1):3-7 PubMed
Am J Surg Pathol. 2006 Dec;30(12):1554-60 PubMed
Hum Pathol. 2006 Nov;37(11):1371-88 PubMed
Mod Pathol. 1997 Jun;10(6):537-44 PubMed
Ann Diagn Pathol. 2013 Apr;17(2):226-9 PubMed
Ann Diagn Pathol. 2015 Aug;19(4):226-31 PubMed
Diagn Pathol. 2008 Sep 03;3:36 PubMed
Mod Pathol. 2009 Jun;22 Suppl 2:S96-S118 PubMed
Cancer Res. 1995 Jun 15;55(12):2681-90 PubMed
Mod Pathol. 2002 Nov;15(11):1126-30 PubMed
Mod Pathol. 2008 Dec;21(12):1533-41 PubMed
Hum Pathol. 2002 Feb;33(2):236-41 PubMed
Arch Pathol Lab Med. 1988 Aug;112(8):847-9 PubMed
Leukemia. 2003 Dec;17(12):2257-317 PubMed
J Biol Chem. 1994 Jan 28;269(4):2440-6 PubMed
Am J Surg Pathol. 2009 May;33(5):659-68 PubMed
Pathol Res Pract. 2011 Apr 15;207(4):271-4 PubMed
Histopathology. 2002 Dec;41(6):549-55 PubMed
Histopathology. 2002 May;40(5):450-7 PubMed
Biochimie. 2010 Jan;92(1):1-11 PubMed
Acta Histochem. 1969;34(2):263-72 PubMed